Top-News
Mittwoch,
22.11.2017 08:50
von
PR Newswire
| Aufrufe: 30
Orexo Completes Early Redemption of Existing Bond Loan
pixabay.com
PR Newswire
UPPSALA, Sweden, Nov. 22, 2017
UPPSALA, Sweden, Nov. 22, 2017 /PRNewswire/ -- Orexo AB (publ.) (the "Company") today announces that the Company, in accordance with Orexo's press release on 31 October 2017, has completed the early total redemption of the existing bond loan (ISIN SE0005932159).
The redemption was made at an amount corresponding to 101 percent of the nominal amount (i.e. SEK 1,010,000 per bond, the nominal amount being SEK 1,000,000) together with accrued but unpaid interest from the preceding interest payment date on November 9 2017 up to, and including, the redemption date on November 22 2017. In conjunction herewith, the bonds are delisted from the corporate bond list of Nasdaq Stockholm.
For further information, please contact:
Orexo AB (publ.)
Nikolaj Sørensen, President and CEO
Tel: +46 (0)18-780-88-00
E-mail: ir@orexo.com
Henrik Juuel, EVP and CFO
Tel: + 46 (0)18-780-88-00
E-mail: ir@orexo.com
About Orexo
Orexo develops improved pharmaceuticals based on innovative drug delivery technologies. The focus is primarily on opioid dependence and pain but the aim is to address therapeutic areas where our competence and technologies can create value. The main market today is the US market for the treatment of opioid dependence where the product Zubsolv® is commercialized by Orexo. Other products are commercialized by license partners, including Zubsolv in markets outside of the US. Total net sales for 2016 amounted to SEK 705.9 million and the number of employees was 102. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) index and is available as ADRs on OTCQX (ORXOY) in the US. The head office, where also research and development is performed, is located in Uppsala, Sweden.
For more information about Orexo please visit, www.orexo.com. You can also follow Orexo on Twitter, @orexoabpubl, LinkedIn and YouTube. For more information about Zubsolv in the US, see the product and market websites www.zubsolv.com and www.rise-us.com .
The information was submitted for publication at 8:30 am CET, November 22, 2017
This information was brought to you by Cision http://news.cision.com
http://news.cision.com/orexo/r/orexo-completes-early-redemption-of-existing-bond-loan,c2396751
The following files are available for download:
View original content:http://www.prnewswire.com/news-releases/orexo-completes-early-redemption-of-existing-bond-loan-300560846.html
SOURCE Orexo
Werbung
Mehr Nachrichten zur Orexo Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
